Clinical & Experimental Metastasis

, Volume 4, Issue 4, pp 285–292 | Cite as

Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs

  • Trevor J. McMillan
  • Ian R. Hart

The effect of in vitro pretreatment of B16 murine melanoma cells with various cancer chemotherapeutic agents on their subsequent experimental metastatic capacity has been examined. Methotrexate, cytosine arabinoside, 5-azacytidine and aphidicolin all produced significant increases in the number of lung nodules formed following the i.v. injection of tumour cells. This effect was not seen with melphalan or 5-fluorouracil. Since the doses of melphalan and 5-fluorouracil used produced similar levels of cell kill to cytosine arabinoside and aphidicolin it appears that a cytotoxic effect was not sufficient to produce increased lung nodule formation. Analysis of the perturbations in the cell cycle induced by the drugs did not reveal any consistent differences between those drugs which enhanced experimental metastasis and those which did not. The precise mechanisms underlying this phenomenon remain to be elucidated but the results are consistent with the possibility that anticancer agents may play a role in assisting tumour progression.


Melanoma Methotrexate Melphalan Melanoma Cell Anticancer Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E., and Bishop, J. M., 1983, Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proceedings of the National Academy of Sciences, USA, 801, 1709–1711.Google Scholar
  2. [2]
    Benedict, W. F., Baker, M. S., Haroum, L., Choi, E., and Ames, B. N., 1979, Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test. Cancer Research, 37, 2210–2213.Google Scholar
  3. [3]
    Bird, A. P., 1984, DNA methylation. How important in gene control. Nature, 307, 503.Google Scholar
  4. [4]
    Boehm, T. L. J., and Drahovsky, D., 1982, Elevated level of enzymatic DNA methylation in cells treated with 1-β-d-arabinofuranosylcytosine. Cancer Research, 42, 1537–1540.Google Scholar
  5. [5]
    Boon, T., and Kellermann, O., 1977, Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proceedings of the National Academy of Sciences, USA, 74, 272–275.Google Scholar
  6. [6]
    Feinstein, A. R., Sosin, D. M., and Wells, C. K., 1985, The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New England Journal of Medicine, 312, 1604–1608.Google Scholar
  7. [7]
    Fidler, I. J., 1973, Selection of successive tumor lines for metastasis. Nature, 242, 148–149.Google Scholar
  8. [8]
    Fidler, I. J., 1973, The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. European Journal of Cancer, 9, 223–227.Google Scholar
  9. [9]
    Fisher, M. S., and Cifone, M. A., 1981, Enhanced metastatic potential of murine fibrosarcoma treated in vitro with ultraviolet radiation. Cancer Research, 41, 3018–3023.Google Scholar
  10. [10]
    Foulds, L., 1954, The experimental study of tumor progression. A review. Cancer Research, 14, 327–339.Google Scholar
  11. [11]
    Frost, P., Kerbel, R. S., Bauer, E., Tartamella-Biondo, R., and Cefalu, W., 1983, Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Research, 43, 125–132.Google Scholar
  12. [12]
    Fulton, A. M., Loveless, S. E., and Heppner, G. H., 1984, Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strain TA98 and TA100, Cancer Research, 11, 1308–4311.Google Scholar
  13. [13]
    Hart, I. R., Talmadge, J. E., and Fidler, I. J., 1983, Comparative studies on the quantitative analysis of experimental metastatic capacity. Cancer Research, 43, 400–402.Google Scholar
  14. [14]
    Hill, A. B., and Schimke, R. T., 1985, Increased gene amplification in L5178Y mouse lymphoma cells with hydroxyurea-induced chromosomal aberrations. Cancer Research, 45, 5050–5057.Google Scholar
  15. [15]
    Ishii, Y., and Bender, M. A., 1980, Effects of inhibitors of DNA synthesis on spontaneous and ultraviolet light-induced sister chromatid exchanges in Chinese hamster cells. Mutation Research, 79, 19–32.Google Scholar
  16. [16]
    Jones, P. A., and Taylor, S. M., 1980, Cellular differentiation, cytidine analogues and DNA methylation. Cell, 20, 85–93.Google Scholar
  17. [17]
    Kcerbel, R. S., and Davies, A. J. S., 1982, Facilitation of tumour progression by cancer therapy. Lancet, 977–978.Google Scholar
  18. [18]
    Lavia, P., Ferraro, M., Micheli, A., and Olivieri, G., 1985, Effect of 5-azacytidine (5azaC) on the induction of chromatid aberrations (CA) and sister-chromatid exchanges (SCE). Mutation Research, 149, 463–467.Google Scholar
  19. [19]
    Lazo, J. S., Ingker, D. E., and Sartorelli, A. C., 1978, Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (±)-1,2 his (3,5dioxopiperazin-1-yl) propane (ICRF-159). Cancer Research, 38, 2263–2270.Google Scholar
  20. [20]
    Lee, W. H., Murphree, A. L., and Benedict, W. F., 1984, Expression and amplification of N-myc gene in primary retinoblastoma. Nature, 309, 458–460.Google Scholar
  21. [21]
    McMillan, T. J., Rao, J., and Hart, I. R., 1986, Enhancement of experimental metastasis by pretreatment of tumour cells with hydroxyurea. International Journal of Cancer, 38, 61–65.Google Scholar
  22. [22]
    Milas, L., Malenica, B., and Allegretti, N., 1979, Enhancement of artificial lung metastases in mice caused by cyclophosphamide. Cancer Immunology and Immunotherapy, 6, 191–196.Google Scholar
  23. [23]
    Moors, J. V., and Dixon, B., 1977, Metastasis of transplantable mammary tumor in rats treated with cyclophosphamide and/or irradiation. British Journal of Cancer, 36, 221–226.Google Scholar
  24. [24]
    Nowell, P. C., 1976, The clonal evolution of tumor cell populations. Science, 194, 23–28.Google Scholar
  25. [25]
    Olsson, L., and Forchhammer, J., 1984, Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine and characterization of an antigen associated with metastatic activity. Proceedings of the National Academy of Sciences, USA, 81, 3389–3393Google Scholar
  26. [26]
    Ormerod, E. J., Everett, C. A., and Hart, I. R., 1986, Enhanced experimental metastatic capacity of a human tumor line following treatment with 5-azacytidine. Cancer Research, 46, 884–890.Google Scholar
  27. [27]
    Poupon, M-F., Pauwels, C., Jasmin, C., Antoine, E., Lascaux, V., and Rosa, B., 1984, Amplified pulmonary metastases of a rat rhabdomyosarcoma in response to nitrosourea treatment. Cancer Treatment Reports, 68, 749–758.Google Scholar
  28. [28]
    Razin, A., and Riggs, D., 1980, DNA methylation and gene function. Science, 210, 604–610.Google Scholar
  29. [29]
    Singh, B., and Gupta, R. S., 1983, Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells. Cancer Research, 43, 577–584.Google Scholar
  30. [30]
    Steel, G. G., and Adams, K., 1977, Enhancement by cytotoxic agents of artificial pulmonary metastasis. British Journal of Cancer, 36, 653–658.Google Scholar
  31. [31]
    Suzuki, N., Frapart, M., Grdina, D. J., Meistrich, M. L., and Withers, H. R., 1977, Cell cycle dependency of metastatic lung colony formation. Cancer Research, 37, 3690–3693.Google Scholar
  32. [32]
    Tlsty, T. D., Brown, P. C., Johnston, R., and Schimke, R. T., 1982, Enhanced frequency of generation of methotrexate resistance and gene amplification in cultured mouse and hamster cell lines. Gene Amplification, edited by R. T. Schimke (New York: Cold Spring Harbor Laboratory), p. 231.Google Scholar
  33. [33]
    Trainer, D. K., Kline, T., Mallon, F., Greig, R., and Posts, G., 1985, Effect of 5azacytidine on DNA methylation and the malignant properties of B16 melanoma cells. Cancer Research, 45, 6124–6130.Google Scholar
  34. [34]
    Van Putten, L. M., Kram, L. K. J., Van Dierendonck, H. H. C., Smink, T., and Fuzy, M., 1975, Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection. International Journal of Cancer, 15, 588–595.Google Scholar

Copyright information

© Taylor & Francis Ltd 1986

Authors and Affiliations

  • Trevor J. McMillan
    • 1
  • Ian R. Hart
    • 1
  1. 1.Imperial Cancer Research FundLondonU.K.

Personalised recommendations